160 related articles for article (PubMed ID: 23400497)
1. Insulin-like growth factor-1 and progression of motor symptoms in early, drug-naïve Parkinson's disease.
Picillo M; Erro R; Santangelo G; Pivonello R; Longo K; Pivonello C; Vitale C; Amboni M; Moccia M; Colao A; Barone P; Pellecchia MT
J Neurol; 2013 Jul; 260(7):1724-30. PubMed ID: 23400497
[TBL] [Abstract][Full Text] [Related]
2. Increased serum insulin-like growth factor 1 in early idiopathic Parkinson's disease.
Godau J; Herfurth M; Kattner B; Gasser T; Berg D
J Neurol Neurosurg Psychiatry; 2010 May; 81(5):536-8. PubMed ID: 20176597
[TBL] [Abstract][Full Text] [Related]
3. Clinical correlates of serum insulin-like growth factor-1 in patients with Parkinson's disease, multiple system atrophy and progressive supranuclear palsy.
Numao A; Suzuki K; Miyamoto M; Miyamoto T; Hirata K
Parkinsonism Relat Disord; 2014 Feb; 20(2):212-6. PubMed ID: 24280021
[TBL] [Abstract][Full Text] [Related]
4. Insulin-Like Growth Factor 1 (IGF-1) in Parkinson's Disease: Potential as Trait-, Progression- and Prediction Marker and Confounding Factors.
Bernhard FP; Heinzel S; Binder G; Weber K; Apel A; Roeben B; Deuschle C; Maechtel M; Heger T; Nussbaum S; Gasser T; Maetzler W; Berg D
PLoS One; 2016; 11(3):e0150552. PubMed ID: 26967642
[TBL] [Abstract][Full Text] [Related]
5. Serum IGF-1 is associated with cognitive functions in early, drug-naïve Parkinson's disease.
Picillo M; Pivonello R; Santangelo G; Pivonello C; Savastano R; Auriemma R; Amboni M; Scannapieco S; Pierro A; Colao A; Barone P; Pellecchia MT
PLoS One; 2017; 12(10):e0186508. PubMed ID: 29065116
[TBL] [Abstract][Full Text] [Related]
6. Insulin-like growth factor-1 predicts cognitive functions at 2-year follow-up in early, drug-naïve Parkinson's disease.
Pellecchia MT; Santangelo G; Picillo M; Pivonello R; Longo K; Pivonello C; Vitale C; Amboni M; De Rosa A; Moccia M; Erro R; De Michele G; Santoro L; Colao A; Barone P
Eur J Neurol; 2014 May; 21(5):802-7. PubMed ID: 23551560
[TBL] [Abstract][Full Text] [Related]
7. Plasma insulin-like growth factor 1 is associated with cognitive impairment in Parkinson's disease.
Ma J; Jiang Q; Xu J; Sun Q; Qiao Y; Chen W; Wu Y; Wang Y; Xiao Q; Liu J; Tang H; Chen S
Dement Geriatr Cogn Disord; 2015; 39(5-6):251-6. PubMed ID: 25661865
[TBL] [Abstract][Full Text] [Related]
8. Serum epidermal growth factor predicts cognitive functions in early, drug-naive Parkinson's disease patients.
Pellecchia MT; Santangelo G; Picillo M; Pivonello R; Longo K; Pivonello C; Vitale C; Amboni M; De Rosa A; Moccia M; Erro R; De Michele G; Santoro L; Colao A; Barone P
J Neurol; 2013 Feb; 260(2):438-44. PubMed ID: 22911513
[TBL] [Abstract][Full Text] [Related]
9. Serum Insulin-Like Growth Factor-1 in Patients with De Novo, Drug Naïve Parkinson's Disease: A Meta-Analysis.
Li DH; He YC; Quinn TJ; Liu J
PLoS One; 2015; 10(12):e0144755. PubMed ID: 26657015
[TBL] [Abstract][Full Text] [Related]
10. Expression of insulin-like growth factor-1 and insulin-like growth factor binding proteins in the serum and cerebrospinal fluid of patients with Parkinson's disease.
Mashayekhi F; Mirzajani E; Naji M; Azari M
J Clin Neurosci; 2010 May; 17(5):623-7. PubMed ID: 20189394
[TBL] [Abstract][Full Text] [Related]
11. Serum Insulin-Like Growth Factor-1 in Parkinson's Disease; Study of Cerebrospinal Fluid Biomarkers and White Matter Microstructure.
Ghazi Sherbaf F; Mohajer B; Ashraf-Ganjouei A; Mojtahed Zadeh M; Javinani A; Sanjari Moghaddam H; Shirin Shandiz M; Aarabi MH
Front Endocrinol (Lausanne); 2018; 9():608. PubMed ID: 30450079
[No Abstract] [Full Text] [Related]
12. Correlation between serum IGF-1 and EGF levels and neuropsychiatric and cognitive in Parkinson's disease patients.
Shi X; Zheng J; Ma J; Li D; Gu Q; Chen S; Wang Z; Sun W; Li M
Neurol Sci; 2023 Mar; 44(3):881-887. PubMed ID: 36383265
[TBL] [Abstract][Full Text] [Related]
13. Serum insulin-like growth factor-1 and nitric oxide levels in Parkinson's disease.
Tuncel D; Inanc Tolun F; Toru I
Mediators Inflamm; 2009; 2009():132464. PubMed ID: 19300521
[TBL] [Abstract][Full Text] [Related]
14. Blood NfL: A biomarker for disease severity and progression in Parkinson disease.
Lin CH; Li CH; Yang KC; Lin FJ; Wu CC; Chieh JJ; Chiu MJ
Neurology; 2019 Sep; 93(11):e1104-e1111. PubMed ID: 31420461
[TBL] [Abstract][Full Text] [Related]
15. Baseline Plasma C-Reactive Protein Concentrations and Motor Prognosis in Parkinson Disease.
Umemura A; Oeda T; Yamamoto K; Tomita S; Kohsaka M; Park K; Sugiyama H; Sawada H
PLoS One; 2015; 10(8):e0136722. PubMed ID: 26308525
[TBL] [Abstract][Full Text] [Related]
16. Increased bilirubin levels in de novo Parkinson's disease.
Moccia M; Picillo M; Erro R; Longo K; Amboni M; Santangelo G; Palladino R; Allocca R; Caporale O; Triassi M; Pellecchia MT; Barone P; Vitale C
Eur J Neurol; 2015 Jun; 22(6):954-9. PubMed ID: 25740378
[TBL] [Abstract][Full Text] [Related]
17. Insulin-like growth factor in Parkinson's disease is related to nonmotor symptoms and the volume of specific brain areas.
Shi X; Zheng J; Ma J; Wang Z; Sun W; Li M; Huang S; Hu S
Neurosci Lett; 2022 Jul; 783():136735. PubMed ID: 35709879
[TBL] [Abstract][Full Text] [Related]
18. Is serum uric acid related to non-motor symptoms in de-novo Parkinson's disease patients?
Moccia M; Picillo M; Erro R; Vitale C; Longo K; Amboni M; Santangelo G; Spina E; De Rosa A; De Michele G; Santoro L; Barone P; Pellecchia MT
Parkinsonism Relat Disord; 2014 Jul; 20(7):772-5. PubMed ID: 24725754
[TBL] [Abstract][Full Text] [Related]
19. Does the MDS-UPDRS provide the precision to assess progression in early Parkinson's disease? Learnings from the Parkinson's progression marker initiative cohort.
Regnault A; Boroojerdi B; Meunier J; Bani M; Morel T; Cano S
J Neurol; 2019 Aug; 266(8):1927-1936. PubMed ID: 31073716
[TBL] [Abstract][Full Text] [Related]
20. Plasma apolipoprotein A1 associates with age at onset and motor severity in early Parkinson's disease patients.
Swanson CR; Berlyand Y; Xie SX; Alcalay RN; Chahine LM; Chen-Plotkin AS
Mov Disord; 2015 Oct; 30(12):1648-56. PubMed ID: 26207725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
